Budesonide
Back to searchMolecule Structure
Scientific Name
Budesonide
Description of the Drug
Budesonide is a corticosteroid used to treat Crohn’s disease, asthma, COPD, hay fever and allergies, and ulcerative colitis.
http://www.drugbank.ca/drugs/DB01222
Brand Name(s)
Aircort, Budeflam aquanase, Budelin novolizer, Budenofalk, Budesonide, Cortiment, Duoresp spiromax, Entocort, Entocort cr, Entocort ec, Ortikos, Preferid, Pulmaxan, Pulmicort, Pulmicort flexhaler, Pulmicort l.s., Pulmicort respules, Rhinocort, Rhinocort allergy, Rhinocort aqua, Rhinocort aqua 64, Symbicort, Tarpeyo, Uceris
Company Owner(s)
Cipla Ltd, Sun Pharmaceutical Industries Inc, Johnson And Johnson Consumer Inc Mcneil Consumer Healthcare Div, Nephron Pharmaceuticals Corp, Mylan Pharmaceuticals Inc, Amneal Pharmaceuticals Of New York Llc, Zydus Pharmaceuticals Usa Inc, Impax Laboratories Inc, Apotex Inc Richmond Hill, Rising Pharma Holdings Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Glucocorticoid receptor | SINGLE PROTEIN | AGONIST | CHEMBL2034 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4096 | ||||||
Human Metabolome Database | HMDB0015353 | ||||||
DrugBank | DB01222 | ||||||
PubChem: Thomson Pharma | 14807548 | 14929955 | |||||
PubChem | 5281004 | ||||||
LINCS | LSM-1472 | ||||||
Nikkaji | J11.656D | ||||||
BindingDB | 50354850 | ||||||
EPA CompTox Dashboard | DTXSID8020202 | ||||||
DrugCentral | 419 | ||||||
Brenda | 52466 | ||||||
ChemicalBook | CB0313122 | ||||||
Guide to Pharmacology | 7434 | ||||||
rxnorm | ORTIKOS | ENTOCORT | PULMICORT | SYMBICORT | BUDESONIDE | RHINOCORT | UCERIS |
PubChem: Drugs of the Future | 12013315 | ||||||
ChEBI | 3207 |